The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model.

Autor: İzci F; Department of Infectious Diseases, Çankırı State Hospital, Çankırı, Turkey., Ture Z; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey. dr.zeynepture@gmail.com., Dinc G; Department of Medical Microbiology, Faculty of Medicine, and Department of Stem Cell GMP Unit of Genome and Stem Cell Centre, Erciyes University, Kayseri, Turkey., Yay AH; Department of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri, Turkey., Eren EE; Department of Infectious Diseases and Clinical Microbiology, Kayseri City Education and Research Hospital, Kayseri, Turkey., Bolat D; Department of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri, Turkey., Gönen ZB; Oral and Maxillofacial Surgery, Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey., Ünüvar GK; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey., Yıldız O; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey., Aygen B; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

Publikováno v: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2023 Nov; Vol. 42 (11), pp. 1365-1372. Date of Electronic Publication: 2023 Oct 09.